Veracyte, Inc.

VCYT · Healthcare · Veracyte, Inc. operates as a diagnostics company in the United States and internationally

Veracyte, Inc. (VCYT), in the Healthcare sector, has 30 disclosed filings on Paydirt over the trailing twelve months from 1 member of Congress and 10 corporate insiders: 2 purchases and 28 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 14 and filed Sep 16. The most active filer was Rebecca Chambers with 6 filings.

Add to watchlist

Filings, ttm

2 buys · 28 sells

Traders, ttm

1 congress · 10 insiders

Volume, ttmiDollar value disclosed in the window

$20.8M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 14

Filed Sep 16

ADViAverage daily dollar volume

$55.3M

market data

Share price · 12M

$39.79 (+17.3%)

Adjusted for splits and dividends.

Volume by month

Buys $24K Sells $27.4M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Rebecca Chambers Chief Financial Officer 6 filings KE

Karin Eastham Director 6 filings MS

Marc Stapley Director 6 filings PF

Phillip G. Febbo Chief Scientific & Med Officer 5 filings JL

John Leite Global Chief Commercial Off 5 filings AM

Annie McGuire SVP, General Counsel 5 filings GC

Gilbert Cisneros Representative 4 filings RE

Robert S Epstein Director 3 filings

Recent filings

Jens HolsteinSALE Director $205K
5,000 sh × $40.95
Exec Sep 14
Filed Sep 16 · 4:08 PM ET Phillip G. FebboSALE Chief Scientific & Med Officer $564K
13,110 sh across 2 lots
Exec Sep 4
Filed Sep 4 · 7:54 PM ET Rebecca ChambersSALE Chief Financial Officer $106K
2,477 sh × $42.81
Exec Sep 4
Filed Sep 4 · 7:54 PM ET Karin EasthamSALE Director $169K
3,200 sh × $52.78
Exec Jun 18
Filed Jun 22 · 5:30 PM ET John LeiteSALE Global Chief Commercial Off $700K
13,975 sh × $50.07
Exec Jun 4
Filed Jun 4 · 5:30 PM ET Marc StapleySALE Chief Executive Officer $6.9M
138,051 sh × $50.12
Exec Jun 4
Filed Jun 4 · 5:30 PM ET Jonathan WygantSALE VP, Chief Accounting Officer $1.1M
24,000 sh × $45.40
Exec May 22
Filed May 27 · 5:30 PM ET Robert S EpsteinSALE Director $440K
10,000 sh × $44.01
Exec May 20
Filed May 22 · 5:30 PM ET Annie McGuireSALE SVP, General Counsel $398K
10,204 sh across 2 lots
Exec May 6
Filed May 8 · 5:30 PM ET Gilbert CisnerosPURCHASE Representative $8K
$1K–15K bracket
Exec Mar 3
Filed Apr 7 Gilbert CisnerosPURCHASE Representative $8K
$1K–15K bracket
Exec Feb 18
Filed Mar 9 Annie McGuireSALE SVP, General Counsel $176K
4,994 sh × $35.29
Exec Mar 4
Filed Mar 6 · 5:30 PM ET John LeiteSALE Chief Commercial Officer-CLIA $185K
5,260 sh × $35.19
Exec Mar 4
Filed Mar 6 · 5:30 PM ET Marc StapleySALE Chief Executive Officer $1.6M
45,523 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET Rebecca ChambersSALE Chief Financial Officer $663K
18,341 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET Phillip G. FebboSALE Chief Scientific & Med Officer $485K
13,425 sh × $36.16
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Annie McGuireSALE SVP, General Counsel $459K
10,639 sh × $43.13
Exec Dec 16 2025
Filed Dec 17 2025 · 5:30 PM ET Gilbert CisnerosSALE Representative $8K
$1K–15K bracket
Exec Nov 12 2025
Filed Dec 15 2025 Karin EasthamSALE Director $872K
19,200 sh across 2 lots
Exec Dec 5 2025
Filed Dec 8 2025 · 5:30 PM ET Marc StapleySALE Chief Executive Officer $361K
7,668 sh across 2 lots
Exec Dec 4 2025
Filed Dec 4 2025 · 5:30 PM ET Rebecca ChambersSALE Chief Financial Officer $622K
13,278 sh across 2 lots
Exec Dec 4 2025
Filed Dec 4 2025 · 5:30 PM ET John LeiteSALE Chief Commercial Officer-CLIA $140K
2,808 sh × $50.00
Exec Nov 25 2025
Filed Nov 26 2025 · 5:30 PM ET Jens HolsteinSALE Director $299K
7,049 sh × $42.48
Exec Nov 20 2025
Filed Nov 21 2025 · 5:30 PM ET Jonathan WygantSALE VP, Chief Accounting Officer $450K
10,920 sh across 2 lots
Exec Nov 7 2025
Filed Nov 12 2025 · 5:30 PM ET Rebecca ChambersSALE Chief Financial Officer $287K
7,000 sh × $41.00
Exec Nov 5 2025
Filed Nov 7 2025 · 5:30 PM ET